IP Library Granted Patent US 10,968,242
Granted Patent B2
US 10,968,242 · App. 16/702,738 · Granted Apr 6, 2021

Cyclopentane-based modulators of STING (stimulator of interferon genes)

Inventors: Martin James Wythes (Solana Beach, CA); Indrawan James McAlpine (San Diego, CA); Ryan Patman (San Diego, CA); Eugene Yuanjin Rui (San Diego, CA); Andreas Maderna (Walnut Creek, CA); Mehran Jalaie (San Diego, CA); Ketan S. Gajiwala (San Diego, CA)
Assignee: Pfizer Inc.
C07F9/65744A61K47/6801A61P35/00C07H19/213
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,968,242
App. No.
16/702,738
Granted
Apr 6, 2021
Kind
B2
Abstract

Compounds of the general formula (I): or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

Claims (8)

1. A method of treating breast cancer in a mammal, the method comprising administering to the mammal a therapeutically effective amount of the compound:

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein said compound or salt is a component of an antibody-drug conjugate.

3. The method of claim 1 , wherein said compound or salt is a component of a particle-based delivery system.

4. The method of claim 1 , wherein the compound is

5. The method of claim 1 , wherein the compound is a pharmaceutically acceptable salt of

6. The method of claim 1 , wherein the compound is a single diastereoisomer of the compound

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →